Suanfarma Suanfarma

X

CAS 3423-25-4 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 3423-25-4
Also known as: 3423-25-4, 259092-15-4, 8-propan-2-yl-8-azabicyclo[3.2.1]octan-3-ol, 8-(propan-2-yl)-8-azabicyclo[3.2.1]octan-3-ol, (3-endo)-3-hydroxy-8-isopropyl-8-azabicyclo[3.2.1]octane, Einecs 222-314-9
Molecular Formula
C10H19NO
Molecular Weight
169.26  g/mol
InChI Key
YYDQYSQZIUSKFN-UHFFFAOYSA-N

1 2D Structure

CAS 3423-25-4

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
8-propan-2-yl-8-azabicyclo[3.2.1]octan-3-ol
2.1.2 InChI
InChI=1S/C10H19NO/c1-7(2)11-8-3-4-9(11)6-10(12)5-8/h7-10,12H,3-6H2,1-2H3
2.1.3 InChI Key
YYDQYSQZIUSKFN-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)N1C2CCC1CC(C2)O
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 3423-25-4

2. 259092-15-4

3. 8-propan-2-yl-8-azabicyclo[3.2.1]octan-3-ol

4. 8-(propan-2-yl)-8-azabicyclo[3.2.1]octan-3-ol

5. (3-endo)-3-hydroxy-8-isopropyl-8-azabicyclo[3.2.1]octane

6. Einecs 222-314-9

7. Ec 222-314-9

8. Ao-801/41077387

9. Schembl10362733

10. Dtxsid10955774

11. Bcp34373

12. Mfcd28010178

13. Akos011240753

14. Sy226328

15. Cs-0450214

16. En300-89000

17. 1alphah,5alphah-nortropan-3alpha-ol, 8-isopropyl-

18. Z905065862

19. 8-azabicyclo[3.2.1]octan-3-ol,8-(1-methylethyl)-(9ci)

2.3 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 169.26 g/mol
Molecular Formula C10H19NO
XLogP31.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count1
Exact Mass169.146664230 g/mol
Monoisotopic Mass169.146664230 g/mol
Topological Polar Surface Area23.5 Ų
Heavy Atom Count12
Formal Charge0
Complexity155
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
3423-25-4
Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, an...
Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, anti-migraine & anti-psychotic APIs, it caters to domestic & international markets(50% sales). Anti-asthma products account for 60% of sales. Vamsi adheres to high corporate governance, transparency, professionalism, & environmental protection standards. It's USFDA approved & ISO 9001:2015, ISO 14001:2015, & ISO 45001:2018 certified. With a DSIR-certified R&D Lab, Vamsi continues to innovate & meet the pharma industry's evolving needs. Vamsi is poised to grow its globally while maintaining its commitment to excellence and sustainability.
Vamsi Labs

PEGS Boston Summit

Not Confirmed

envelop Contact Supplier
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY